Longwood Capital Partners »

Entrada Therapeutics shares owned by Longwood Capital Partners

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Longwood Capital Partners from 13F filings

Historical chart of Longwood Capital Partners investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Longwood Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Longwood Capital Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.1M 89k 12.62